Amneal Pharmaceuticals (AMRX) Net Income towards Common Stockholders (QoQ) (2018 - 2026)
Amneal Pharmaceuticals (AMRX) Net Income towards Common Stockholders (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Amneal Pharmaceuticals | 4.84 Bn | 4.84 Bn | 320.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.34% |
| Dec 31, 2025 | 173.40% |
| Sep 30, 2025 | -49.08% |
| Jun 30, 2025 | 44.65% |
| Mar 31, 2025 | 218.69% |
| Dec 31, 2024 | -276.42% |
| Sep 30, 2024 | -29.96% |
| Jun 30, 2024 | 120.55% |
| Mar 31, 2024 | 17.20% |
| Dec 31, 2023 | -1,118.89% |
| Sep 30, 2023 | -18.75% |
| Jun 30, 2023 | 271.64% |
| Mar 31, 2023 | -60.24% |
| Dec 31, 2022 | -61.14% |
| Sep 30, 2022 | 97.77% |
| Jun 30, 2022 | -5,503.34% |
| Mar 31, 2022 | 66.19% |
| Dec 31, 2021 | -50.51% |
| Sep 30, 2021 | -129.16% |
| Jun 30, 2021 | 116.70% |